BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 27434126)

  • 21. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
    Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
    BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation.
    Costa AF; Tasso MG; Mariano FV; Soares AB; Chone CT; Crespo AN; Fresno MF; Llorente JL; Suárez C; de Araújo VC; Hermsen M; Altemani A
    Histopathology; 2012 Apr; 60(5):816-25. PubMed ID: 22320429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-1α and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma.
    Kwon OJ; Park JJ; Ko GH; Seo JH; Jeong BK; Kang KM; Woo SH; Kim JP; Hwa JS; Carey TE
    Head Neck; 2015 Apr; 37(4):505-10. PubMed ID: 24677746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.
    Vleugel MM; Greijer AE; Shvarts A; van der Groep P; van Berkel M; Aarbodem Y; van Tinteren H; Harris AL; van Diest PJ; van der Wall E
    J Clin Pathol; 2005 Feb; 58(2):172-7. PubMed ID: 15677538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.
    Hoogsteen IJ; Marres HA; Bussink J; van der Kogel AJ; Kaanders JH
    Head Neck; 2007 Jun; 29(6):591-604. PubMed ID: 17252597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
    Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
    Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgically induced ischemia has no impact on protein expression levels of HIF-1α and related biomarkers in renal cell carcinoma.
    Mikkelsen ML; Marcussen N; Rabjerg M
    APMIS; 2021 Sep; 129(9):535-547. PubMed ID: 33948984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
    Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
    Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma.
    Peterle GT; Maia LL; Trivilin LO; de Oliveira MM; Dos Santos JG; Mendes SO; Stur E; Agostini LP; Rocha LA; Moysés RA; Cury PM; Nunes FD; Louro ID; Dos Santos M; da Silva AMÁ
    J Oral Pathol Med; 2018 Jul; 47(6):566-574. PubMed ID: 29693741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factors in OSCC.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Barros-Angueira F; Gándara-Rey JM; García-García A
    Cancer Lett; 2011 Dec; 313(1):1-8. PubMed ID: 21959110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
    Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrotic focus and hypoxia in male breast cancer.
    Kornegoor R; Verschuur-Maes AH; Buerger H; Hogenes MC; de Bruin PC; Oudejans JJ; Hinrichs B; van Diest PJ
    Mod Pathol; 2012 Oct; 25(10):1397-404. PubMed ID: 22684218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
    Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
    Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
    Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
    Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relation between carbonic anhydrase IX serum level, hypoxia and radiation resistance of head and neck cancers].
    Rosenberg V; Pastoreková S; Zaťovičová M; Slezák P; Waczulíková I; Svec J
    Klin Onkol; 2014; 27(4):269-75. PubMed ID: 25115716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation.
    Jensen R; Lee J
    Neurosurgery; 2012 Jul; 71(1):146-56. PubMed ID: 22472549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous hypoxia markers: case not proven!
    Mayer A; Höckel M; Vaupel P
    Adv Exp Med Biol; 2008; 614():127-36. PubMed ID: 18290322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.